HIGHLIGHTS
- who: Hui Shan and colleagues from the Institute of Pathogen Biology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China have published the paper: Eriodictyol Suppresses Gastric Cancer Cells via Inhibition of PI3K/AKT Pathway, in the Journal: Pharmaceuticals 2022, 15, 1477. of /2022/
- what: The authors compared the anti-GC effects of the main flavonoids from POF and investigated the anti-cancer effects of towards GC both in vitro and in vivo. The authors demonstrated that eriodictyol significantly inhibited cell viability of GC cells, and the inhibitory effect was time . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.